findmyKOL

Gregory Barkley, MD

Basic profile

Henry Ford Health System

ORCIDNone on fileNPI
RegionDetroit, MI · MidwestSpecialtyNeurologyFocusNeurology
Last active 2023findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPaymentsNone reportedNIH funding1995–2000Why? →

Gregory Barkley is a Neurology physician affiliated with Henry Ford Health System. OpenAlex indexes 106 publications with 6,316 citations (h-index 36); ClinicalTrials.gov lists 2 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
106publications

Distinct works indexed by OpenAlex.

6,316citations

Total citations across indexed works.

36h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
2NIH grants · 1995–2000

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2799 W Grand Blvd
Detroit, MI 482022608

Telephone

313-916-2600

Registry record last updated 8 Jul 2007.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    87%
    Other antiepileptics23.2%
    Epidiolex34%Levetiracetam23%Lacosamide18%Topiramate12%Keppra3%Briviact3%Vimpat3%Xcopri1%Levetiracetam Er1%Topamax1%
    Part D<11 patients
    Benzodiazepine18.8%
    Clonazepam49%Lorazepam22%Clobazam10%Diazepam10%Alprazolam5%Nayzilam4%
    Part D<11 patients

    + 25 more classes in this area

  • Cardiovascular

    4.3%
    Angiotensin receptor blocker (ARB)1.8%
    Losartan Potassium100%
    Part D27 patients
    Statin0.9%
    Atorvastatin Calcium100%
    Part D16 patients

    + 5 more classes in this area

  • Respiratory

    3.4%
    Opioid Agonist3.1%
    Hydrocodone-Acetaminophen100%
    Part D21 patients
    Corticosteroid0.3%
    Fluticasone Propionate100%
    Part D<11 patients
Where care is delivered (Part B)94.1% facility · 5.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

2 NIH research awards on record, funded 19952000 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”